Literature DB >> 6047854

Haemolysis and agranulocytosis complicating treatment with methyldopa.

K G Clark.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1967        PMID: 6047854      PMCID: PMC1748495          DOI: 10.1136/bmj.4.5571.94

Source DB:  PubMed          Journal:  Br Med J        ISSN: 0007-1447


× No keyword cloud information.
  6 in total

1.  Thrombocytopenia in a patient taking chlorpropamide.

Authors:  W J GRACE
Journal:  N Engl J Med       Date:  1959-04-02       Impact factor: 91.245

2.  Fatal marrow aplasia during chlorpropamide therapy.

Authors:  L L WHITE
Journal:  Br Med J       Date:  1962-03-10

3.  The mixed antiglobulin reaction in the detection of human isoantibodies against leucocytes, platelets and HeLa cells.

Authors:  D G CHALMERS; R R COOMBS; B W GURNER; J DAUSSET
Journal:  Br J Haematol       Date:  1959-07       Impact factor: 6.998

4.  Fatal agranulocytosis following chlorpropamide treatment of diabetes. Report of a case.

Authors:  H KARLIN
Journal:  N Engl J Med       Date:  1960-05-26       Impact factor: 91.245

5.  Autoimmune haemolytic anaemia associated with alpha-methyldopa therapy.

Authors:  S M Worlledge; K C Carstairs; J V Dacie
Journal:  Lancet       Date:  1966-07-16       Impact factor: 79.321

6.  Agranulocytosis caused by methyl dopa (Aldomet).

Authors:  G P HALLWRIGHT
Journal:  N Z Med J       Date:  1961-12
  6 in total
  1 in total

1.  Editorial: Side effects of methyldopa.

Authors: 
Journal:  Br Med J       Date:  1975-03-22
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.